Information for Reviewer

JKB telah terindex di Crossref JKB telah terindex di Google Scholar JKB telah terindex di SINTA Ristekdikti JKB telah terindex di Portal Garuda

Journal Content

Visitor Counter


Plasma Glucagon-Like Peptide-1 and Cholecystokinin Responses to Fast Food in Healthy-Weight and Obese Men

Dian Handayani, Dianita Setya Pradita Putri, Hidayat Sujuti, Sri Andarini, Widya Rahmawati, Inggita Kusumastuty, Leny Budhi Harti, Nindy Sabrina
  Jurnal Kedokteran Brawijaya, Vol 31, No 1 (2020),  pp.69-75  


Satiety hormones play a role in obesity metabolism. The satiety response to similar nutrients in food in healthy and obese men remains undefined. The research was aimed to determine the satiety response differences by comparing the effect of isocaloric fast-food consumption on reducing appetite-related gut hormones, such as glucagon-like fullness ratings and both GLP-1 and CCK among healthy and obese men. Respondents were given an isocaloric fast food, then GLP-1 and CCK levels were measured using enzyme-linked immunosorbent assay (ELISA). Visual analogue scale (VAS) form was used for hunger and fullness ratings of the subjects. The difference level of GLP-1, CCK, and VAS between groups were measured by t-test. The correlation between VAS hunger and fullness rating was measured by Pearson. Plasma hormone levels in 16 obese and 16 healthy-weight respondents were assessed before eating and at 30, 60, and 120 minutes after consumption. In obese men, GLP-1 levels were significantly higher than those in healthy-weight men at 60 and 120 minutes, while healthy-weight men had significantly higher CCK levels than those of obese men over time (all p<0.05). The total area under the curve (AUC) for GLP-1 was significantly higher for obese men than for healthy-weight men, while the AUC for CCK was significantly higher for healthy-weight men than for obese men. Obese men have higher plasma GLP-1 levels and lower plasma CCK than healthy men indicates that those respondents were experiencing glucose intolerance and leptin alteration. The hormonal systems that may contribute to the development of obesity need further investigation.


Cholecystokinin, glucagon-like peptide 1; obesity; visual analogue scale of hunger; visual analogue scale of fullness

Full Text:



Board HR. Basic Health Research. Jakarta: Mohro Editor; 2013.

Rolls BJ, Roe LS, and Meengs JS. Portion Size Can Be Used Strategically to Increase Vegetable Consumption in Adults. The American Journal of Clinical Nutrition. 2010; 91(4): 913-922.

Rahmawati W and Handayani D. Different Recipes and Energy Density of Indonesia Fast Food on Percentage of Indonesian Daily Value. Obesity & Control Therapies. 2014; 1(1): 1-5.

Currie J, DellaVigna S, Moretti E, and Pathania V. The Effect of Fast Food Restaurants on Obesity and Weight Gain. American Economic Journal: Economic Policy. 2010; 2(3): 32-63.

Myers MG Jr., Leibel RL, Seeley RJ, and Schwartz MW. Obesity and Leptin Resistance: Distinguishing Cause from Effect. Trends in Endocrinology and Metabolism. 2010; 21(11): 643-651.

Attie AD and Scherer PE. Adipocyte Metabolism and Obesity. Journal of Lipid Research. 2009; 50: S395-S399.

Holst JJ. The Physiology of Glucagon-Like Peptide 1. Physiological Reviews. 2007; 87(4): 1409-1439.

Perry B and Wang Y. Appetite Regulation and Weight Control: The Role of Gut Hormones. Nutrition & Diabetes. 2012; 2(1): 1-7.

Sundaresan S, Shahid R, Riehl TE, et al. CD36-Dependent Signaling Mediates Fatty Acid-Induced Gut Release of Secretin and Cholecystokinin. Federation of American Societies for Experimental Biology Journal. 2013; 27(3): 1191-1202.

Wang Y, Chandra R, Samsa LA, et al. Amino Acids Stimulate Cholecystokinin Release Through the Ca2+-Sensing Receptor. The American Journal of Physiology. Gastrointestinal and Liver Physiology. 2011; 300(4): G528-G537.

Klimek L, Bergmann KC, Biedermann T, et al. Visual Analogue Scales (VAS): Measuring Instruments for the Documentation of Symptoms and Therapy Monitoring in Cases of Allergic Rhinitis in Everyday Health Care: Position Paper of the German Society of Allergology (Aeda) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in Collaboration with the Working Group on Clinical Immunology, Allergology and Environmental Medicine of The German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo Journal International. 2017; 26(1): 16-24.

Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia No: 28 Tahun 2019 Tentang Angka Kecukupan Gizi yang Dianjurkan Bagi Bangsa Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia; 2019.

Handayani D, Oktafiani LDA, Abednego RT, and Andarini S. Effect of International and Indonesian Fast Foods on Plasma Ghrelin and Glucagon Like Peptide-1 (GLP-1) Levels, Hunger and Satiety Scores is Similar in Obese Adults. Pakistan Journal of Nutrition. 2017; 16(1): 38-44.

Handayani D, Rahmawati W, Kusumastuty I, Harti LB, Wahyuni ES, and Andarini S. Plasma Ghrelin, PYY and CCK Concentration Following Indonesian Fast Food and Western Fast Food in Obese Participant. Food and Nutrition Sciences. 2016; 7(9): 724-731.

Flint A, Raben A, Blundell J, and Astrup A. Reproducibility, Power and Validity of Visual Analogue Scales in Assessment of Appetite Sensations in Single Test Meal Studies. International Journal of Obesity. 2000; 24: 38-48.

Flint A, Moller BK, Raben A, et al. Glycemic And Insulinemic Responses As Determinants Of Appetite In Humans. The American Journal of Clinical Nutrition. 2006; 84(6): 1365-1373.

Ravassa S, Zudaire A, and Diez J. GLP-1 and Cardioprotection: From Bench to Bedside. Cardiovascular Research. 2012; 94(2): 316-323.

Andarini S, Kangsaputra FB, and Handayani D. Pre- and Postprandial Acylated Ghrelin in Obese and Normal Weight Men. Asia Pacific Journal of Clinical Nutrition. 2017; 26(1): S85-S91.

Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, and Astrup A. The Role of Postprandial Releases of Insulin and Incretin Hormones in Meal-Induced Satiety-Effect of Obesity and Weight Reduction. International Journal of Obesity and Related Metabolic Disorders. 2001; 25(8): 1206-1214.

Rask E, Olsson T, Soderberg S, et al. Impaired Incretin Response after a Mixed Meal is Associated with Insulin Resistance in Nondiabetic Men. Diabetes Care. 2001; 24(9): 1640-1645.

Vilsboll T, Krarup T, Sonne J, et al. Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology and Metabolism. 2003; 88(6): 2706-2713.

Nakajima S, Hira T, and Hara H. Postprandial Glucagon-Like Peptide-1 Secretion is Increased During the Progression of Glucose Intolerance and Obesity in High-Fat/High-Sucrose Diet-Fed Rats. The British Journal of Nutrition. 2015; 113(9): 1477-1488.

Shah M and Vella A. Effects of GLP-1 on Appetite and Weight. Reviews in Endocrine & Metabolic Disorders. 2014; 15(3): 181-187.

Madsbad S. The Role of Glucagon-Like Peptide-1 Impairment in Obesity and Potential Therapeutic Implications. Diabetes, Obesity & Metabolism. 2014; 16(1): 9-21.

Guilmeau S, Buyse M, Tsocas A, Laigneau JP, and Bado A. Duodenal Leptin Stimulates Cholecystokinin Secretion: Evidence of a Positive Leptin-Cholecystokinin Feedback Loop. Diabetes. 2003; 52(7): 1664-1672.

Zhou Y and Rui L. Leptin Signaling and Leptin Resistance. Frontiers of Medicine. 2013; 7(2): 207-220.

Balland E and Cowley MA. New Insights in Leptin Resistance Mechanisms in Mice. Frontiers in Neuroendocrinology. 2015; 39: 59-65.

Pandit R, Mercer JG, Overduin J, la Fleur SE, and Adan RA. Dietary Factors Affect Food Reward and Motivation to Eat. Obesity Facts. 2012; 5(2): 221-242.

de Git KC and Adan RA. Leptin Resistance in Diet-Induced Obesity: The Role of Hypothalamic Inflammation. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity. 2015; 16(3): 207-224.

Green SM, Delargy HJ, Joanes D, and Blundell JE. A Satiety Quotient: A Formulation To Assess The Satiating Effect Of Food. Appetite. 1997; 29(3): 291-304.

Melhorn SJ, Tyagi V, Smeraglio A, Roth CL, and Schur EA. Initial Evidence that GLP-1 Receptor Blockade Fails to Suppress Postprandial Satiety or Promote Food Intake in Humans. Appetite. 2014; 82: 85-90.



  • There are currently no refbacks.